as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹1,374.2
Change
-38.4 (-2.72%)
Open
₹1,410.0
Prev. Close
₹1,412.6
Day High
₹1,422.3
Day Low
₹1,350.0
Volume Analysis
Traded
433,047
Delivered
240,964
Delivery %
55.64%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (32.0%)
Weaknesses (0)
No signal for this stock
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹1,486.64 | ₹1,454.47 | ₹1,414.34 | ₹1,382.17 | ₹1,342.04 | ₹1,309.87 | ₹1,269.74 |
| Fibonacci | ₹1,454.47 | ₹1,426.85 | ₹1,409.79 | ₹1,382.17 | ₹1,354.55 | ₹1,337.49 | ₹1,309.87 |
| Camarilla | ₹1,394.08 | ₹1,387.46 | ₹1,380.83 | ₹1,382.17 | ₹1,367.57 | ₹1,360.95 | ₹1,354.32 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+4.47%
1 Week
-4.54%
1 Month
-4.75%
3 Months
-2.83%
6 Months
+16.93%
1 Year
+0.91%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹316.03
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
16.33%
Net margin 15.93% × asset turnover 0.61x × equity multiplier 1.68x
Company Overview
Sector
Healthcare
Market Cap
₹13,957 Cr
P/E (TTM)
48.7
ROE
15.9%
Book Value
₹162.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.
TopFund Analysis
Rainbow Childrens Med Ltd holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 71/100. The strongest factor is Risk & Volatility (93/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (32.0%). FII holding has been falling.
TopFund Score — Fundamentals Quality
71/100 — GoodData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company's median sales growth is 22.8% of last 10 years
- −Stock is trading at 8.47 times its book value
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Trading window closes October 1, 2026; reopens 48 hours after Q2 FY27 results.
Rainbow Childrens Medicare updates authorised KMP contact details under Regulation 30(5).
Board appointed Sudarshan Patodia as CFO and Group CFO effective September 23, 2026.
NRC granted 55,690 stock options under ESOP 2025; 1,922 exercised, ₹23.95 lakh realized.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 287 | 333 | 336 | 341 | 330 | 417 | 398 | 370 | 353 | 445 | 445 | 460 | 470 |
| Expenses + | 199 | 215 | 218 | 236 | 236 | 270 | 264 | 255 | 249 | 296 | 298 | 315 | 335 |
| Operating Profit | 88 | 118 | 118 | 106 | 94 | 147 | 134 | 115 | 104 | 149 | 147 | 145 | 135 |
| OPM % | 31.0% | 35.0% | 35.0% | 31.0% | 28.0% | 35.0% | 34.0% | 31.0% | 29.0% | 33.0% | 33.0% | 31.0% | 29.0% |
| Other Income + | 8 | 8 | 9 | 13 | 12 | 11 | 13 | 15 | 20 | 8 | 11 | 4 | 13 |
| Interest | 15 | 13 | 14 | 17 | 18 | 18 | 18 | 18 | 18 | 19 | 20 | 20 | 21 |
| Depreciation | 25 | 27 | 28 | 32 | 34 | 35 | 35 | 34 | 34 | 36 | 40 | 41 | 42 |
| Profit before tax | 56 | 85 | 85 | 69 | 53 | 105 | 94 | 77 | 71 | 102 | 98 | 87 | 84 |
| Tax % | 25.0% | 26.0% | 26.0% | 26.0% | 26.0% | 25.0% | 27.0% | 27.0% | 25.0% | 26.0% | 24.0% | 10.0% | 26.0% |
| Net Profit + | 42 | 63 | 63 | 51 | 40 | 79 | 69 | 57 | 54 | 76 | 74 | 78 | 63 |
| EPS in Rs | 4 | 6 | 6 | 5 | 4 | 8 | 7 | 6 | 5 | 7 | 7 | 8 | 6 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 169 | 234 | 321 | 402 | 543 | 719 | 650 | 974 | 1,174 | 1,297 | 1,516 | 1,703 | 1,820 |
| Expenses + | 128 | 204 | 266 | 332 | 391 | 519 | 485 | 666 | 774 | 865 | 1,022 | 1,155 | 1,245 |
| Operating Profit | 41 | 30 | 55 | 69 | 151 | 201 | 165 | 308 | 400 | 432 | 494 | 548 | 575 |
| OPM % | 24.0% | 13.0% | 17.0% | 17.0% | 28.0% | 28.0% | 25.0% | 32.0% | 34.0% | 33.0% | 33.0% | 32.0% | 32.0% |
| Other Income + | 10 | 16 | 11 | 10 | 8 | 10 | 10 | 19 | 31 | 37 | 51 | 42 | 35 |
| Interest | 3 | 3 | 3 | 4 | 42 | 48 | 46 | 56 | 58 | 63 | 77 | 82 | 81 |
| Depreciation | 9 | 18 | 22 | 28 | 60 | 69 | 73 | 83 | 90 | 112 | 138 | 151 | 159 |
| Profit before tax | 38 | 24 | 41 | 47 | 58 | 93 | 56 | 187 | 282 | 295 | 330 | 358 | 371 |
| Tax % | 35.0% | 28.0% | 24.0% | 22.0% | 22.0% | 41.0% | 29.0% | 26.0% | 25.0% | 26.0% | 26.0% | 21.0% | — |
| Net Profit + | 25 | 17 | 31 | 36 | 45 | 55 | 40 | 139 | 212 | 218 | 244 | 282 | 290 |
| EPS in Rs | 27 | 18 | 34 | 8 | 10 | 13 | 9 | 15 | 21 | 21 | 24 | 27 | 28 |
| Dividend Payout % | 7.0% | 11.0% | 7.0% | 12.0% | 10.0% | 16.0% | 0.0% | 14.0% | 14.0% | 14.0% | 13.0% | 13.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 166 | 275 | 308 | 307 | 317 | 350 | 391 | 498 | 958 | 1,157 | 1,367 | 1,547 |
| Borrowings + | 22 | 24 | 26 | 24 | 476 | 501 | 529 | 592 | 570 | 765 | 764 | 891 |
| Other Liabilities + | 34 | 41 | 55 | 73 | 89 | 123 | 116 | 112 | 140 | 146 | 145 | 236 |
| Total Liabilities | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,771 | 2,170 | 2,377 | 2,775 |
| Fixed Assets + | 78 | 123 | 174 | 296 | 702 | 702 | 772 | 858 | 931 | 1,253 | 1,398 | 1,756 |
| CWIP | 35 | 31 | 7 | 12 | 23 | 43 | 29 | 6 | 23 | 20 | 28 | 79 |
| Investments | 7 | 2 | 6 | 0 | 3 | 10 | 18 | 22 | 58 | 308 | 571 | 404 |
| Other Assets + | 111 | 194 | 212 | 140 | 199 | 265 | 262 | 409 | 759 | 590 | 380 | 535 |
| Total Assets | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,771 | 2,170 | 2,377 | 2,775 |
| Equity Capital | 9 | 9 | 9 | 44 | 44 | 44 | 44 | 94 | 102 | 102 | 102 | 102 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 26 | 17 | 36 | 48 | 127 | 170 | 143 | 224 | 329 | 321 | 396 | 420 |
| Cash from Investing Activity + | -20 | -107 | -33 | -42 | -117 | -117 | -83 | -175 | -465 | -226 | -268 | -259 |
| Cash from Financing Activity + | -7 | 93 | -1 | -7 | -9 | -52 | -61 | -44 | 143 | -102 | -118 | -147 |
| Net Cash Flow | -1 | 3 | 1 | -2 | 2 | 2 | -1 | 4 | 7 | -7 | 10 | 14 |
| CFO/OP | 95 | 88 | 79 | 88 | 94 | 95 | 102 | 93 | 103 | 95 | 97 | 95 |
| Free Cash Flow | -35 | -46 | -21 | -103 | 42 | 96 | 67 | 162 | 188 | -32 | 250 | 204 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Others | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.04% | 0.12% | 0.18% |
| Public | 13.14% | 12.23% | 11.37% | 11.53% | 11.2% | 11.16% | 11.14% | 11.11% | 10.82% | 11.4% | 11.68% | 11.39% |
| Promoters | 49.83% | 49.83% | 49.83% | 49.87% | 49.85% | 49.85% | 49.85% | 49.85% | 49.85% | 49.84% | 49.84% | 49.84% |
| FII | 21.63% | 22.32% | 24.04% | 24.78% | 25.12% | 25.12% | 23.69% | 23.6% | 21.85% | 19.24% | 17.24% | 16.03% |
| DII | 15.39% | 15.62% | 14.76% | 13.81% | 13.84% | 13.87% | 15.31% | 15.44% | 17.46% | 19.49% | 21.12% | 22.56% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Rainbow Childrens Med Ltd (this stock) | 13,957 | 48.7 | 8.48 | 15.9% |
| Indegene Limited | 14,319 | 34.4 | 4.57 | 14.4% |
| Corona Remedies Limited | 13,219 | 62.3 | 17.73 | 29.5% |
| Sudeep Pharma Limited | 13,157 | 72.0 | 14.9 | 25.2% |
| Natco Pharma Ltd. | 15,033 | 13.1 | 1.63 | 17.1% |
| Akums Drugs And Pharma L | 12,869 | 42.2 | 3.88 | 8.45% |
| Molbio Diagnostics Ltd | 15,118 | 60.6 | — | 15.6% |
Which Mutual Funds Hold Rainbow Childrens Med Ltd?
Frequently Asked Questions about Rainbow Childrens Med Ltd
Rainbow Childrens Med Ltd (RAINBOW) closed at ₹1,374.2 on NSE on 25 September 2026, down 38.4 (2.72%) from the previous close.
Rainbow Childrens Med Ltd trades on the NSE (National Stock Exchange of India) under the symbol RAINBOW.
Rainbow Childrens Med Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 48.7.
Rainbow Childrens Med Ltd has a dividend yield of 0.25%.
Rainbow Childrens Med Ltd's 52-week high is ₹1,610.0 and its 52-week low is ₹1,009.0.
Rainbow Childrens Med Ltd has a market capitalisation of ₹13,957 crore.
Rainbow Childrens Med Ltd has a TopFund Quality Score of 71/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Rainbow Childrens Med Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.